Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2010 Filed Jul 1, 2010 18:14 UTC |
KELLEY WILLAM NDirector
|
GrantPhantom Stock · Derivative | 636.2597 | $34.97 | $22,250.00 |
DisclosureSEC source: 0001225208-10-015976 · doc4.xml · derivative · entry 3 KELLEY WILLAM N · CIK 0001204361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,743.4396 Underlying: Common Stock · 636.2597 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:15 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 436.0881 | $34.97 | $15,250.00 |
DisclosureSEC source: 0001225208-10-015978 · doc4.xml · derivative · entry 4 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,155.115 Underlying: Common Stock · 436.0881 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:15 UTC |
REPRESAS CARLOS EDirector
|
GrantPhantom Stock · Derivative | 636.2597 | $34.97 | $22,250.00 |
DisclosureSEC source: 0001225208-10-015979 · doc4.xml · derivative · entry 2 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,974.8096 Underlying: Common Stock · 636.2597 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:16 UTC |
TATLOCK ANNE MDirector
|
GrantPhantom Stock · Derivative | 593.3657 | $34.97 | $20,750.00 |
DisclosureSEC source: 0001225208-10-015981 · doc4.xml · derivative · entry 3 TATLOCK ANNE M · CIK 0001020567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,551.8066 Underlying: Common Stock · 593.3657 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:17 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 581.4698 | $34.97 | $20,334.00 |
DisclosureSEC source: 0001225208-10-015982 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,775.8247 Underlying: Common Stock · 581.4698 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:18 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 564.7698 | $34.97 | $19,750.00 |
DisclosureSEC source: 0001225208-10-015985 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,288.2387 Underlying: Common Stock · 564.7698 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:54 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014274 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,952.8769 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:54 UTC |
Cech Thomas RDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014275 · doc4.xml · derivative · entry 2 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,614.6489 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:55 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014280 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241.8519 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:56 UTC |
GOLDSTONE STEVEN FDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014281 · doc4.xml · derivative · entry 2 GOLDSTONE STEVEN F · CIK 0001210409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,814.7499 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:57 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014282 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,772.3299 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:58 UTC |
JACOBSON HARRY RDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014283 · doc4.xml · derivative · entry 3 JACOBSON HARRY R · CIK 0001255835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,930.3359 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:58 UTC |
KELLEY WILLAM NDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014284 · doc4.xml · derivative · entry 3 KELLEY WILLAM N · CIK 0001204361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,107.1799 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:59 UTC |
KIDDER C ROBERTDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014285 · doc4.xml · derivative · entry 3 KIDDER C ROBERT · CIK 0001179703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,395.0719 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:00 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014286 · doc4.xml · derivative · entry 4 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,719.0269 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:00 UTC |
REPRESAS CARLOS EDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014288 · doc4.xml · derivative · entry 2 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,338.5499 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:01 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014289 · doc4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,395.0719 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:02 UTC |
SHENK THOMAS EDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014301 · doc4.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,830.9209 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:03 UTC |
TATLOCK ANNE MDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014304 · doc4.xml · derivative · entry 3 TATLOCK ANNE M · CIK 0001020567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,958.4409 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:03 UTC |
Thompson Craig B.Director
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014305 · doc4.xml · derivative · entry 2 Thompson Craig B. · CIK 0001423419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,395.0709 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:04 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014306 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194.3549 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:05 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014307 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,723.4689 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:23 UTC |
AMBROSE ADELE DV-P & Chief Comms Officer
|
GrantStock Option (right to buy) · Derivative | 19,208 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012604 · doc4.xml · derivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · V-P & Chief Comms Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,208 Underlying: Common Stock · 19,208 shares Expires 2020-05-06 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:23 UTC |
AMBROSE ADELE DV-P & Chief Comms Officer
|
GrantRestricted Stock Unit · Derivative | 3,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012604 · doc4.xml · derivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · V-P & Chief Comms Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 3,583 shares Expires 2013-05-07 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:25 UTC |
CLARK RICHARD TChairman, Pres & CEO
|
GrantStock Option (right to buy) · Derivative | 672,269 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012608 · doc4.xml · derivative · entry 4 CLARK RICHARD T · CIK 0001181282 · Chairman, Pres & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672,269 Underlying: Common Stock · 672,269 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:25 UTC |
CLARK RICHARD TChairman, Pres & CEO
|
GrantRestricted Stock Unit · Derivative | 83,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012608 · doc4.xml · derivative · entry 3 CLARK RICHARD T · CIK 0001181282 · Chairman, Pres & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,607 Underlying: Common Stock · 83,607 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:27 UTC |
Canan JohnSr V-P & Controller
|
GrantStock Option (right to buy) · Derivative | 24,010 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012610 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr V-P & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,010 Underlying: Common Stock · 24,010 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:27 UTC |
Canan JohnSr V-P & Controller
|
GrantRestricted Stock Unit · Derivative | 4,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012610 · doc4.xml · derivative · entry 3 Canan John · CIK 0001374366 · Sr V-P & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479 Underlying: Common Stock · 4,479 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:28 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 87,635 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012611 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,635 Underlying: Common Stock · 87,635 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:28 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantRestricted Stock Unit · Derivative | 14,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012611 · doc4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,631 Underlying: Common Stock · 14,631 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:30 UTC |
FRAZIER KENNETH CExe V-P & Pres Global HH
|
GrantStock Option (right to buy) · Derivative | 228,091 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012612 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Exe V-P & Pres Global HH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,091 Underlying: Common Stock · 228,091 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:30 UTC |
FRAZIER KENNETH CExe V-P & Pres Global HH
|
GrantRestricted Stock Unit · Derivative | 35,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012612 · doc4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Exe V-P & Pres Global HH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,832 Underlying: Common Stock · 35,832 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:31 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantStock Option (right to buy) · Derivative | 210,084 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012613 · doc4.xml · derivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,084 Underlying: Common Stock · 210,084 shares Expires 2020-05-06 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:31 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantRestricted Stock Unit · Derivative | 37,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012613 · doc4.xml · derivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,325 Underlying: Common Stock · 37,325 shares Expires 2013-05-07 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:32 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 180,072 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012614 · doc4.xml · derivative · entry 4 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,072 Underlying: Common Stock · 180,072 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:32 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantRestricted Stock Unit · Derivative | 29,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012614 · doc4.xml · derivative · entry 3 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,860 Underlying: Common Stock · 29,860 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:33 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 117,647 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012616 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,647 Underlying: Common Stock · 117,647 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:33 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantRestricted Stock Unit · Derivative | 22,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012616 · doc4.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,096 Underlying: Common Stock · 22,096 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:33 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantStock Option (right to buy) · Derivative | 176,471 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012617 · doc4.xml · derivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,471 Underlying: Common Stock · 176,471 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:33 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantRestricted Stock Unit · Derivative | 33,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012617 · doc4.xml · derivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,144 Underlying: Common Stock · 33,144 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:34 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 36,014 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012619 · doc4.xml · derivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,014 Underlying: Common Stock · 36,014 shares Expires 2020-05-06 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:34 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantRestricted Stock Unit · Derivative | 4,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012619 · doc4.xml · derivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479 Underlying: Common Stock · 4,479 shares Expires 2013-05-07 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:35 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantStock Option (right to buy) · Derivative | 78,031 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,031 Underlying: Common Stock · 78,031 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:35 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantRestricted Stock Unit · Derivative | 13,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,437 Underlying: Common Stock · 13,437 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:36 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantStock Option (right to buy) · Derivative | 60,024 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012621 · doc4.xml · derivative · entry 2 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,024 Underlying: Common Stock · 60,024 shares Expires 2020-05-06 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:36 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantRestricted Stock Unit · Derivative | 29,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012621 · doc4.xml · derivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,860 Underlying: Common Stock · 29,860 shares Expires 2013-05-07 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:41 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 65,335 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012626 · doc4.xml · derivative · entry 3 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,335 Underlying: Common Stock · 65,335 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:41 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantRestricted Stock Unit · Derivative | 12,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012626 · doc4.xml · derivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 Underlying: Common Stock · 12,188 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:23 UTC |
KOHAN RAUL EExe V-P & Pres, Animal Health
|
GrantStock Option (right to buy) · Derivative | 48,019 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012651 · doc4.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,019 Underlying: Common Stock · 48,019 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:23 UTC |
KOHAN RAUL EExe V-P & Pres, Animal Health
|
GrantRestricted Stock Unit · Derivative | 5,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012651 · doc4.xml · derivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,972 Underlying: Common Stock · 5,972 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.